These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9687327)

  • 1. Management of the N(0) neck.
    Breau RL; Suen JY
    Otolaryngol Clin North Am; 1998 Aug; 31(4):657-69. PubMed ID: 9687327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of the clinically negative (N0) neck.
    Pitman KT; Dean R
    Curr Oncol Rep; 2002 Jan; 4(1):81-6. PubMed ID: 11734118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N0 neck in head and neck cancer patients.
    Eur Arch Otorhinolaryngol; 1993; 250(8):423. PubMed ID: 8129917
    [No Abstract]   [Full Text] [Related]  

  • 4. Classification of neck dissection: current concepts and future considerations.
    Robbins KT
    Otolaryngol Clin North Am; 1998 Aug; 31(4):639-55. PubMed ID: 9687326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planned postradiotherapy neck dissection in patients with advanced head and neck cancer.
    Boyd TS; Harari PM; Tannehill SP; Voytovich MC; Hartig GK; Ford CN; Foote RL; Campbell BH; Schultz CJ
    Head Neck; 1998 Mar; 20(2):132-7. PubMed ID: 9484944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel node biopsy for oral cancer: A prospective multicenter Phase II trial.
    Miura K; Hirakawa H; Uemura H; Yoshimoto S; Shiotani A; Sugasawa M; Homma A; Yokoyama J; Tsukahara K; Yoshizaki T; Yatabe Y; Matsuo K; Ohkura Y; Kosuda S; Hasegawa Y
    Auris Nasus Larynx; 2017 Jun; 44(3):319-326. PubMed ID: 27496008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cancer of the head and neck.
    Shah JP; Lydiatt W
    CA Cancer J Clin; 1995; 45(6):352-68. PubMed ID: 7583907
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of the N0 neck during salvage surgery after radiotherapy of head and neck squamous cell carcinoma.
    Temam S; Koka V; Mamelle G; Julieron M; Carmantrant R; Marandas P; Janot F; Bourhis J; Luboinski B
    Head Neck; 2005 Aug; 27(8):653-8. PubMed ID: 16035097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neck lymph node metastases to the posterior triangle apex: evaluation of clinical and histopathological risk factors.
    Chone CT; Crespo AN; Rezende AS; Carvalho DS; Altemani A
    Head Neck; 2000 Sep; 22(6):564-71. PubMed ID: 10941157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of recurrences in the primary tumor site in relation to the histologic involvement of the regional lymph nodes in patients with carcinoma of the head and neck.
    Basso Ricci S
    Rays; 1985; 10(1):113-6. PubMed ID: 3843627
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of excisional or incisional biopsy of metastatic neck nodes on the management of head and neck cancer.
    Parsons JT; Million RR; Cassisi NJ
    Int J Radiat Oncol Biol Phys; 1985 Aug; 11(8):1447-54. PubMed ID: 4019269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elective modified neck dissection for treatment of the clinically negative (N0) neck.
    Callender DL; Weber RS
    Cancer Treat Res; 1995; 74():221-41. PubMed ID: 7779618
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic decision making in stages III and IV head and neck squamous cell carcinoma.
    Gleich LL; Collins CM; Gartside PS; Gluckman JL; Barrett WL; Wilson KM; Biddinger PW; Redmond KP
    Arch Otolaryngol Head Neck Surg; 2003 Jan; 129(1):26-35. PubMed ID: 12525191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Classification of neck dissection].
    Yoshino K
    Nihon Jibiinkoka Gakkai Kaiho; 2013 Aug; 116(8):986-7. PubMed ID: 24312976
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of the clinically negative neck in advanced cancer of the head and neck.
    Weissler MC; Weigel MT; Rosenman JG; Silver JR
    Arch Otolaryngol Head Neck Surg; 1989 Jun; 115(6):691-4. PubMed ID: 2719827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy pf cervical lymph node metastases of unknown primary tumor].
    Kirschner MJ; Fietkau R; Waldfahrer F; Iro H; Sauer R
    Strahlenther Onkol; 1997 Jul; 173(7):362-8. PubMed ID: 9265258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamous cell carcinoma of the head and neck treated with radiation therapy: the role of neck dissection for clinically positive neck nodes.
    Mendenhall WM; Million RR; Cassisi NJ
    Int J Radiat Oncol Biol Phys; 1986 May; 12(5):733-40. PubMed ID: 3710857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of the clinically positive neck as part of a larynx preservation approach.
    Armstrong J; Pfister D; Strong E; Heimann R; Kraus D; Polishook A; Zelefsky M; Bosl G; Shah J; Spiro R
    Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):759-65. PubMed ID: 8344843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?
    Chen AM; Farwell DG; Lau DH; Li BQ; Luu Q; Donald PJ
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):346-52. PubMed ID: 20933340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.